Q2 2017 Holdings
Filed 2017-08-14 | 26 holdings | $4.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $3.7M | 176,500 | 77.1% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $622.0K | 22,400 | 12.8% |
| Ardelyx, Inc.(ARDX) | COM | 039697107 | $191.0K | 37,500 | 3.9% |
| Aerie Pharmaceuticals, Inc.(AERIEUR) | COM | 00771V108 | $102.5K | 1,950,477 | 2.1% |
| Achaogen, Inc. | COM | 004449104 | $27.2K | 1,250,000 | 0.6% |
| Alder BioPharmaceuticals, Inc.(ALDR1EUR) | COM | 014339105 | $24.9K | 2,177,203 | 0.5% |
| Blueprint Medicines Corporation(2L9) | COM | 09627Y109 | $23.3K | 460,000 | 0.5% |
| Aimmune Therapeutics, Inc.(AIMT) | COM | 00900T107 | $18.8K | 912,001 | 0.4% |
| Wave Life Sciences Ltd.(WVE) | SHS | Y95308105 | $18.7K | 1,004,100 | 0.4% |
| Immunomedics, Inc.(IMMU) | COM | 452907108 | $17.1K | 1,940,850 | 0.4% |
| Epizyme, Inc.(EPZMEUR) | COM | 29428V104 | $12.1K | 799,363 | 0.2% |
| Tocagen, Inc. | COM | 888846102 | $9.1K | 753,000 | 0.2% |
| Loxo Oncology, Inc. | COM | 548862101 | $9.0K | 112,500 | 0.2% |
| Fibrogen, Inc.(FGENEUR) | COM | 31572Q808 | $8.1K | 250,000 | 0.2% |
| Verona Pharma Plc(VRNA) | SPONSORED ADS | 925050106 | $7.2K | 613,601 | 0.1% |
| Bellicum Pharmaceuticals, Inc. | COM | 079481107 | $5.3K | 452,727 | 0.1% |
| Dermira, Inc.(DERMEUR) | COM | 24983L104 | $5.1K | 176,211 | 0.1% |
| Pacific Biosciences of California, Inc.(PACB) | COM | 69404D108 | $4.5K | 1,250,000 | 0.1% |
| NanoString Technologies, Inc.(NSTGEUR) | COM | 63009R109 | $3.0K | 178,681 | 0.1% |
| Sangamo Therapeutics Inc.(SGMO) | COM | 800677106 | $1.4K | 154,000 | 0.0% |
| Infinity Pharmaceuticals, Inc.(INFIQ) | COM | 45665G303 | $1.2K | 738,896 | 0.0% |
| Orexigen Therapeutics, Inc. | COM | 686164302 | $1.1K | 380,530 | 0.0% |
| Zafgen, Inc. | COM | 98885E103 | $822 | 234,092 | 0.0% |
| Biohaven Pharmaceutical Holding Company Ltd.(BHVN) | COM | G11196105 | $750 | 30,000 | 0.0% |
| Acceleron Pharma Inc.(XLRN) | COM | 00434H108 | $604 | 19,886 | 0.0% |
| Abeona Therapeutics, Inc.(ABEO1EUR) | COM | 00289Y107 | $117 | 18,334 | 0.0% |